Department of Biochemistry, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
J Physiol Pharmacol. 2011 Feb;62(1):65-73.
Development of ulcerative colitis was accompanied by the activation of iNOS/COX-2/5-LOX and increased contents of nitric oxide (NO), prostaglandin E₂ (PGE₂), and leukotriene B₄ (LTB₄). The following information was assessed: morphological changes, activity of nitric oxide-synthase, content of nitric oxide, and indexes of lipoperoxidation processes in the mucous membrane of the large intestine (MMLI). Colitis was induced in rats by intrarectal administration of 1 ml of 4% acetic acid. Aminoguanidine--selective inducible nitric oxide-synthase (iNOS) blocker, celecoxib--cyclooxygenase-2 (COX-2) inhibitor, indomethacin--non-selective COX inhibitor and AA-861--5-lipooxygenase (5-LOX) blocker were administered in 1 ml volumes per os 1 hour before and 24 hours after the intrarectal application of acetic acid. It was noticed that blockage of iNOS by aminoguanidine caused enhancement of cytoprotective mechanisms, reduction of iNOS activity and oxidative stress, and an increase in blood L-arginine level as compared to their respective indexes in colitis. Combined blockage of iNOS and COX-2 displayed additive character of their effect on the processes of lipoperoxidation and activity of iNOS. Combined blockage of iNOS, COX-2 and 5-LOX had a manifested cytoprotective effect under condition of ulcerative colitis and was accompanied by a sharp decline in NOS activity and oxidative stress. If each of these systems, iNOS/NO, COX-2/PGE₂ and 5-LOX/LTB₄ are simultaneously activated due to inflammation, they contribute to the destructive damage of the MMLI, development of oxidative stress, and affect components of the antioxidant protection system. The obtained results substantiate the relevance of treatment of the inflammatory processes with the use of medication capable of combined blockage of iNOS, COX-2, and 5-LOX.
溃疡性结肠炎的发展伴随着 iNOS/COX-2/5-LOX 的激活和一氧化氮(NO)、前列腺素 E₂(PGE₂)和白三烯 B₄(LTB₄)含量的增加。评估了以下信息:大肠黏膜(MMLI)的形态变化、一氧化氮合酶活性、NO 含量和脂质过氧化过程指标。通过直肠内给予 1ml 4%醋酸诱导大鼠结肠炎。在直肠内给予醋酸前 1 小时和后 24 小时,给予氨基胍——选择性诱导型一氧化氮合酶(iNOS)阻断剂、塞来昔布——环氧化酶-2(COX-2)抑制剂、吲哚美辛——非选择性 COX 抑制剂和 AA-861——5-脂氧合酶(5-LOX)阻断剂,体积为 1ml。结果表明,与结肠炎时的相应指标相比,氨基胍阻断 iNOS 导致细胞保护机制增强,iNOS 活性和氧化应激降低,血液 L-精氨酸水平增加。iNOS 和 COX-2 的联合阻断表现出对脂质过氧化过程和 iNOS 活性的相加作用。在溃疡性结肠炎条件下,iNOS、COX-2 和 5-LOX 的联合阻断具有明显的细胞保护作用,同时 iNOS 活性和氧化应激急剧下降。如果由于炎症,这些系统中的每一个,即 iNOS/NO、COX-2/PGE₂ 和 5-LOX/LTB₄ 同时被激活,它们会导致 MMLI 的破坏性损伤、氧化应激的发展,并影响抗氧化保护系统的成分。这些结果证实了使用能够联合阻断 iNOS、COX-2 和 5-LOX 的药物治疗炎症过程的相关性。